NCT05826223

Brief Summary

Sepsis is a dysregulated host response to infection resulting in organ dysfunction. Over the past three decades, more than 30 pharmacological therapies have been tested in \>100 clinical trials and have failed to show consistent benefit in the overall population of patients with sepsis. The one-size-fits-all approach has not worked. This has resulted in a shift in research towards identifying sepsis subphenotypes through unsupervised learning. The ultimate objective is to identify sepsis subphenotypes with different responses to therapies, which could provide a path towards the precision medicine approach to sepsis. The investigators have previously discovered sepsis subphenotypes in retrospective data using trajectories of vital signs in the first 8 hours of hospitalization. The team aims to prospectively classify adult hospitalized patients into these subphenotypes in a prospective, observational study. This will be done through the implementation of an electronic health record integrated application that will use vital signs from hospitalized patients to classify the patients into one of four subphenotypes. This study will continue until 1,200 patients with infection are classified into the sepsis subphenotypes. The classification of the patients is only performed to validate the association of the subphenotypes with clinical outcomes as was shown in retrospective studies. Physicians and providers treating the patients will not see the classification, and the algorithm classifying the patients will in no way affect the care of the patients. Further, all the data needed for the algorithm (vital signs from the first 8 hours) are standard of care, and enrollment in the prospective study does not require any additional data.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,916

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2025

Shorter than P25 for all trials

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 12, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 24, 2023

Completed
2.4 years until next milestone

Study Start

First participant enrolled

September 18, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 14, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 14, 2026

Completed
Last Updated

February 23, 2026

Status Verified

February 1, 2026

Enrollment Period

4 months

First QC Date

April 12, 2023

Last Update Submit

February 20, 2026

Conditions

Keywords

phenotypessub-phenotypesinfectionvital signssubphenotypes

Outcome Measures

Primary Outcomes (1)

  • In-hospital mortality

    Comparison of 30 day in-hospital mortality rate between the 4 subphenotypes.

    Up to 30 days

Secondary Outcomes (7)

  • Renal replacement therapy (RRT)

    Through study completion, on average 30 days

  • Mechanical ventilation

    Through study completion, on average 30 days

  • Vasopressor use

    Through study completion, on average 30 days

  • Inotrope use

    Through study completion, on average 30 days

  • Admission to the intensive care unit (ICU)

    Through study completion, on average 30 days

  • +2 more secondary outcomes

Interventions

The algorithm will run silently in the background and continuously compute the subphenotypes of patients who are presenting to the emergency department (ED) with suspected infection.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All adult patients who present to the emergency department at the participating facilities will automatically be enrolled in the study until the enrollment target for the study is met. All patients will be classified into subphenotypes using the algorithm, but the subgroup that will be analyzed will be patients with suspected infection.

You may qualify if:

  • All adults who present to the emergency department

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Emory Hospital Midtown

Atlanta, Georgia, 30308, United States

Location

Emory Saint Joseph's Hospital

Atlanta, Georgia, 30308, United States

Location

Emory University Hospital

Atlanta, Georgia, 30322, United States

Location

Emory Johns Creek Hospital

Johns Creek, Georgia, 30097, United States

Location

Related Publications (1)

  • Bhavani SV, Semler M, Qian ET, Verhoef PA, Robichaux C, Churpek MM, Coopersmith CM. Development and validation of novel sepsis subphenotypes using trajectories of vital signs. Intensive Care Med. 2022 Nov;48(11):1582-1592. doi: 10.1007/s00134-022-06890-z. Epub 2022 Sep 24.

MeSH Terms

Conditions

SepsisInfections

Condition Hierarchy (Ancestors)

Systemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Sivasubramanium Bhavani, MD

    Emory University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

April 12, 2023

First Posted

April 24, 2023

Study Start

September 18, 2025

Primary Completion

January 14, 2026

Study Completion

January 14, 2026

Last Updated

February 23, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations